Treatment of hypercholesterolaemia with PCSK-9 Inhibitors in Denmark. Assessment of real-life data; safety an extent of adverse effects after the first years of clinical use.
31 August 2019 (11:00 - 16:00)
Organised by:
Abstract
About the speaker
Bispebjerg University Hospital, Copenhagen (Denmark)
8 More presentations in this session
Access the full session
The Event
ESC Congress 2019
31 August 2019
11:00 CET
